Literature DB >> 6163521

Identification, purification, and radioimmunoassay of NB/70K, a human ovarian tumor-associated antigen.

S Knauf, G I Urbach.   

Abstract

NB/70K, a tumor-associated antigen of human ovarian epithelial tumor Fraction OCA, has been purified and identified as a glycoprotein which is stable in 0.6 M perchloric acid, binds to concanavalin A, and migrates electrophoretically with alpha-like mobility in barbital-buffered agarose at pH 8.6. NB/70K does not appear to contain normal serum, normal ovary, normal lung, or carcinoembryonic antigen-like cross-reacting antigenic determinants as measured by radioimmunoassay. NB/70K has been purified from ovarian antigen Fraction OCA by chromatography on gamma-globulin coupled to Sepharose 4B and by elution from acrylamide gels. NB/70K migrates as a single band with an apparent molecular weight of 70,000 in sodium dodecyl sulfate:acrylamide gel electrophoresis. A rabbit antibody raised against NB/70K was able to precipitate a polypeptide with a molecular weight of 70,000 as visualized by autoradiography of sodium dodecyl sulfate:acrylamide gels. A radioimmunoassay has been developed for measuring NB/70K activity, using Staphylococcus aureus protein A as a precipitating agent.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163521

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Monoclonal antibodies against human ovarian tumor associated antigen NB/70K: preparation and use in a radioimmunoassay for measuring NB/70K in serum.

Authors:  S Knauf; J Kalwas; B F Helmkamp; L W Harwell; J Beecham; E M Lord
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Studies of a tumor-associated antigen, COX-1, recognized by a monoclonal antibody.

Authors:  C Y Lee; K W Chen; F S Sheu; A Tsang; K C Chao; H T Ng
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

3.  Role of CD47 in tumor immunity: a potential target for combination therapy.

Authors:  Jing Huang; Fangkun Liu; Chenglong Li; Xisong Liang; Chuntao Li; Yuanyuan Liu; Zhenjie Yi; Liyang Zhang; Siqi Fu; Yu Zeng
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

4.  Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma.

Authors:  Yinuo Li; Shuhua Lu; Ying Xu; Chunping Qiu; Chengjuan Jin; Yuqiong Wang; Zhaojian Liu; Beihua Kong
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.